Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
YS Biopharma (YS)
NASDAQ:YS
YS Biopharma (YS) Stock Price & Analysis
62 Followers
YS Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.35 - $1.78
Previous Close$0.9
Volume109.17K
Average Volume (3M)189.06K
Market Cap
$182.68M
Enterprise Value$188.18M
Total Cash (Recent Filing)$53.90M
Total Debt (Recent Filing)$72.56M
Price to Earnings (P/E)N/A
Beta0.30
Next Earnings
Aug 13, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding93,058,200
10 Day Avg. Volume99,699
30 Day Avg. Volume189,062
Standard Deviation0.26
R-Squared0.01
Alpha-0.03
Financial Highlights & Ratios
Price to Book (P/B)0.13
Price to Sales (P/S)0.84
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit2.42
Enterprise Value/Ebitda-292.04
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
YS Biopharma News
Ownership Overview
0.00%
Insiders
<0.01% Mutual Funds
4.33% Other Institutional Investors
95.66% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
YS FAQ
What was YS Biopharma’s price range in the past 12 months?
YS Biopharma lowest stock price was $0.35 and its highest was $1.78 in the past 12 months.
What is YS Biopharma’s market cap?
Currently, no data Available
When is YS Biopharma’s upcoming earnings report date?
YS Biopharma’s upcoming earnings report date is Aug 13, 2024 which is in 91 days.
How were YS Biopharma’s earnings last quarter?
Currently, no data Available
Is YS Biopharma overvalued?
According to Wall Street analysts YS Biopharma’s price is currently Overvalued.
Does YS Biopharma pay dividends?
YS Biopharma does not currently pay dividends.
What is YS Biopharma’s EPS estimate?
YS Biopharma’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does YS Biopharma have?
YS Biopharma has 188,327,960 shares outstanding.
What happened to YS Biopharma’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of YS Biopharma?
Among the largest hedge funds holding YS Biopharma’s share is Pinpoint Asset Management Ltd. It holds YS Biopharma’s shares valued at 26K.
---
YS Biopharma Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
YS Sentiment 100%
Sector Average 70%
Sector Average 70%
Crowd Wisdom
Very Positive
Last 7 Days ▲ 3.2%
Last 30 Days ▲ 3.0%
Last 30 Days ▲ 3.0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-28.67%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
5.84%
Trailing 12-Months
Company Description
YS Biopharma
Summit Healthcare Acquisition Corp is a blank check company. It is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.
---
YS Stock 12 Month Forecast
Average Price Target
―Technical Analysis
Best Analysts Covering YS
1 Year
1 Year Success Rate
1/1 ratings generated profit
1 Year Average Return
+67.20%
initiated a buy rating 6 months ago
Copying Gregory Aurand's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +67.20% per trade.
---